Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening.
作者信息
Lieberman David A
机构信息
Division of Gastroenterology and Hepatology, Oregon Health and Science University, Portland, Oregon.
出版信息
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1160-1164.e1. doi: 10.1016/j.cgh.2024.01.034. Epub 2024 Mar 26.
Abstract
摘要
相似文献
1
Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening.
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1160-1164.e1. doi: 10.1016/j.cgh.2024.01.034. Epub 2024 Mar 26.
2
The Next Frontier for Colorectal Cancer Screening: Blood-Based Tests.
Cancer Res. 2024 Oct 1;84(19):3128-3129. doi: 10.1158/0008-5472.CAN-24-1620.
3
Colorectal cancer screening: Modalities and adherence.
World J Gastroenterol. 2024 Jun 28;30(24):3048-3051. doi: 10.3748/wjg.v30.i24.3048.
4
Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives.
Cells. 2022 Nov 4;11(21):3493. doi: 10.3390/cells11213493.
5
Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Clin Epigenetics. 2019 Dec 2;11(1):175. doi: 10.1186/s13148-019-0779-x.
6
MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):274-282. doi: 10.1016/j.bbcan.2018.05.006. Epub 2018 May 29.
7
Delivering on the promise of early detection with liquid biopsies.
Br J Cancer. 2022 Feb;126(3):313-315. doi: 10.1038/s41416-021-01646-w. Epub 2022 Jan 10.
8
From the EACR-ESMO liquid biopsy meeting.
Nat Rev Clin Oncol. 2019 Aug;16(8):466. doi: 10.1038/s41571-019-0237-x.
9
Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.
Mol Cancer. 2024 Jul 16;23(1):145. doi: 10.1186/s12943-024-02063-2.
10
Novel Diagnostic Biomarkers in Colorectal Cancer.
Int J Mol Sci. 2022 Jan 13;23(2):852. doi: 10.3390/ijms23020852.
引用本文的文献
1
Cancer Screening Progress and Noninvasive Screening Opportunities since the Onset of the COVID-19 Pandemic.
Cancer Prev Res (Phila). 2025 Jun 2;18(6):313-319. doi: 10.1158/1940-6207.CAPR-25-0007.
2
Detection of Early-Stage Colorectal Cancer Using Cell-Free oncRNA Biomarkers and Artificial Intelligence.
Clin Cancer Res. 2025 Aug 1;31(15):3229-3238. doi: 10.1158/1078-0432.CCR-25-0449.
3
How Good Is Good Enough? What Should Be the Target for CRC Screening?
Dig Dis Sci. 2024 Dec 13. doi: 10.1007/s10620-024-08698-x.
4
Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer.
Ann Intern Med. 2024 Dec;177(12):1610-1620. doi: 10.7326/ANNALS-24-00910. Epub 2024 Oct 29.
本文引用的文献
1
Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy.
Gastroenterology. 2024 Jul;167(2):378-391. doi: 10.1053/j.gastro.2024.03.011. Epub 2024 Mar 26.
2
Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test.
Gastroenterology. 2023 Jul;165(1):252-266. doi: 10.1053/j.gastro.2023.03.206. Epub 2023 Mar 21.
3
Stool-Based Screening Tests for Colorectal Cancer.
JAMA. 2023 Mar 14;329(10):839-840. doi: 10.1001/jama.2023.0547.
4
Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020.
JAMA Netw Open. 2023 Jan 3;6(1):e2251384. doi: 10.1001/jamanetworkopen.2022.51384.
5
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
N Engl J Med. 2022 Oct 27;387(17):1547-1556. doi: 10.1056/NEJMoa2208375. Epub 2022 Oct 9.
6
Current and future colorectal cancer screening strategies.
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):521-531. doi: 10.1038/s41575-022-00612-y. Epub 2022 May 3.
7
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes.
Hematol Oncol Clin North Am. 2022 Jun;36(3):415-428. doi: 10.1016/j.hoc.2022.02.003. Epub 2022 Apr 30.
8
Association between Improved Colorectal Screening and Racial Disparities.
N Engl J Med. 2022 Feb 24;386(8):796-798. doi: 10.1056/NEJMc2112409.
9
An examination of socioeconomic and racial/ethnic disparities in the awareness, knowledge and utilization of three colorectal cancer screening modalities.
SSM Popul Health. 2021 Mar 24;14:100780. doi: 10.1016/j.ssmph.2021.100780. eCollection 2021 Jun.
10
Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.
Gut. 2022 Mar;71(3):561-567. doi: 10.1136/gutjnl-2020-322192. Epub 2021 Mar 31.
Zotero 插件